Chylomicrons

Why This Matters

Every meal containing fat initiates the formation of chylomicrons. These are the largest lipoproteins in the circulation and the body's primary transport system for dietary triglycerides. Although they circulate only briefly, chylomicrons play a critical role in nutrient delivery and energy metabolism. Understanding their metabolism provides the foundation for understanding hypertriglyceridemia, chylomicronemia, and pancreatitis.

What Are Chylomicrons?

Chylomicrons are the largest and least dense lipoproteins. They are synthesized by intestinal enterocytes after the absorption of dietary fat and transport triglycerides, cholesterol, fat-soluble vitamins, and other dietary lipids from the intestine to peripheral tissues.

Their lipid core consists predominantly of triglycerides, making them much larger than all other circulating lipoproteins.

Formation of Chylomicrons

Following a fat-containing meal, dietary triglycerides are broken down within the intestinal lumen into free fatty acids and monoglycerides, which are absorbed by enterocytes. Inside these cells, triglycerides are reassembled and packaged with cholesterol, phospholipids, and apolipoprotein B-48 to form nascent chylomicrons.

These newly formed particles enter the lymphatic system before reaching the bloodstream through the thoracic duct, bypassing the portal circulation.

Once in the circulation, they acquire additional apolipoproteins, including ApoC-II and ApoE, from HDL, becoming fully functional transport particles.

Delivery of Dietary Triglycerides

As chylomicrons circulate, they encounter lipoprotein lipase attached to the capillary endothelium of adipose tissue, skeletal muscle, and cardiac muscle.

Activated by ApoC-II, lipoprotein lipase hydrolyzes the triglycerides within chylomicrons, releasing free fatty acids that are either oxidized for energy or stored in adipose tissue. Glycerol returns to the liver, where it may be used for gluconeogenesis or triglyceride synthesis.

As triglycerides are removed, chylomicrons become progressively smaller, forming chylomicron remnants.

Chylomicron Remnants

After most of their triglyceride content has been removed, chylomicron remnants remain enriched in cholesterol and cholesteryl esters.

These remnants retain ApoE, which allows them to bind hepatic receptors and be rapidly removed from the circulation. Under normal physiological conditions, this process is highly efficient, and chylomicrons are rarely detected in fasting plasma.

Failure to clear chylomicron remnants contributes to remnant hyperlipidemia and may increase cardiovascular risk.

Chylomicrons and Atherosclerosis

Because of their large size, intact chylomicrons generally do not penetrate the arterial wall and are not considered directly atherogenic.

Their remnants, however, are substantially smaller and can enter the arterial intima. These cholesterol-rich remnant particles may become retained within the arterial wall and contribute to the development of atherosclerosis.

This distinction explains why remnant lipoproteins have received increasing attention as contributors to residual cardiovascular risk — a topic taken up in depth later in this handbook.

Disorders of Chylomicron Metabolism

Impaired clearance of chylomicrons results in severe hypertriglyceridemia.

Inherited deficiencies of lipoprotein lipase, ApoC-II, GPIHBP1, LMF1, or other components of the lipolytic pathway may produce familial chylomicronemia syndrome. Patients often present with triglyceride levels exceeding 1,000 mg/dL and are at high risk for recurrent acute pancreatitis.

Secondary causes, including uncontrolled diabetes mellitus, excessive alcohol consumption, hypothyroidism, pregnancy, obesity, and certain medications, may also impair chylomicron clearance and markedly elevate triglyceride levels.

Clinical Relevance

The presence of fasting chylomicrons is always abnormal and indicates a major disturbance in triglyceride metabolism.

Recognition of severe hypertriglyceridemia is essential because the immediate clinical concern is pancreatitis rather than atherosclerotic cardiovascular disease. Treatment focuses on rapidly lowering triglyceride concentrations through dietary fat restriction, correction of secondary causes, optimization of glycemic control when appropriate, and pharmacologic therapy in selected patients.

Clinical Pearls

• Chylomicrons transport dietary triglycerides from the intestine.
• ApoB-48 is the structural protein of chylomicrons.
• ApoC-II activates lipoprotein lipase, allowing triglyceride hydrolysis.
• Chylomicron remnants are normally cleared rapidly by the liver.
• Persistent fasting chylomicrons indicate severe impairment of triglyceride metabolism.

Common Misconceptions

Misconception: Chylomicrons are highly atherogenic.

Reality: Intact chylomicrons are generally too large to enter the arterial wall. Their remnants, however, may contribute to atherosclerosis.

Misconception: Elevated triglycerides always indicate increased cardiovascular risk.

Reality: Extremely high triglyceride levels primarily increase the risk of acute pancreatitis, whereas cardiovascular risk depends more on the concentration of remnant and other ApoB-containing lipoproteins.

Misconception: Chylomicrons circulate continuously.

Reality: Chylomicrons are produced after fat-containing meals and are normally cleared from the circulation within several hours.

Clinical Bottom Line

Chylomicrons are the body's transport system for dietary triglycerides. Their rapid metabolism allows efficient delivery of dietary fat to peripheral tissues while preventing prolonged exposure to triglyceride-rich lipoproteins. Failure of this system results in severe hypertriglyceridemia and markedly increases the risk of acute pancreatitis.